Prof. dr. Christophe Moreno, M.D.
Christophe is a professor in gastroenterology and hepatology and clinical director of the liver unit at CUB Hôpital Erasme, Brussels, Belgium. He is an important consultant to the NASH Clinical team.
Genome-wide association studies have uncovered robust and reproducible associations between several genetic variations and the natural history of NAFLD. During this webinar, Professor Eric Trépo reviewed these findings that have provided compelling new insights into the biology of NAFLD and highlighted potentially attractive pharmaceutical targets. Professor Eric Trépo also discussed potential applications and limitations of genetic variations for risk prediction in this disease
Speaker: Prof. Eric Trépo
Host: Prof. Manuel Castro Cabezas
Co-host: Prof. Christophe Moreno
During the 5th Global NASH Congress in London, Our Chief Scientific Officer Prof. Dr. D.E. Grobbee was one of the speakers and presented: Getting GRIP on NASH; Implementation of an International Clinical Screening Program. During this presentat...
In this webinar, Prof. Jörn Schattenberg discussed his paper in Nature Reviews Gastroenterology & Hepatology on effective and efficient models of care for patients with NAFLD. Standardized patient care pathways for NAFLD are not yet widely im...
Topics that has been discussed: The Impact of NAFLD/NASH What is being done to tackle NAFLD/NASH globally and nationally What still needs to be done in the fight against NAFLD/NASH How can you/your country advance the battle against ...